Injective is making significant strides in the crypto space as it integrates with OpenLedger, a move that reflects the increasing institutional interest in its network. Recent developments, including new listings and ETF filings, underscore the growing recognition of Injective's potential. The publication provides the following information:
Revolut Adds Injective's Native Token INJ
Revolut has recently added Injective's native token, INJ, to its platform, enabling users to stake their tokens without incurring any fees. This listing not only enhances user engagement but also signals a broader acceptance of Injective within mainstream financial services.
Institutional Interest in Injective
In addition to Revolut's listing, institutional players like Canary Capital and 21Shares have taken steps to file for exchange-traded funds (ETFs) that focus on Injective. These filings are expected to provide a more structured investment vehicle for institutional investors, further expanding access to the Injective network and potentially driving up demand for its token.
Recently, Injective has gained attention in the institutional investment sector, highlighted by its listing on Revolut and ETF filings. For more details, see read more.
